SIGLEAvailable from British Library Document Supply Centre-DSC:4224.84956(no 06/2000) / BLDSC - British Library Document Supply CentreGBUnited Kingdo
The online version of this article, along with updated information and services, is located on th
Objective. Intrathecal baclofen (ITB) has become the first choice in the management of deleterious s...
This study reports the use of intrathecal baclofen in two ventilator‐dependent children with severe ...
Spasticity may cause immobility, prostration, chronic pain, bedsores, infections, thrombosis and pne...
In the treatment of patients with severe spasticity, intrathecal administration of baclofen (ITB) wa...
Intrathecal baclofen infusion has demonstrated effectiveness in decreasing spasticity of spinal orig...
Flexor and extensor spasms associated with severe spasticity frequently cause pain and suffering in ...
The aim of this thesis was to introduce the intrathecal baclofen delivery method and assessment of i...
Continuous delivery of intrathecal baclofen via an implantable pump was first used to treat severe i...
The purpose of this article is to review the literature on the effects of intrathe-cal[v administere...
Background/Aim. Spasticity is the consequence of several clinical conditions including cerebral pals...
Continuous intrathecal baclofen infusion (CIBI) for spasticity of spinal and cerebral origin has bee...
AimsIntrathecal baclofen (ITB) has proven to be an effective and safe treatment for severe spasticit...
The neuromotor techniques do not have good results in severe spasticity prevention and treatment (As...
Objective. Intrathecal baclofen (ITB) has become the first choice in the management of deleterious s...
The online version of this article, along with updated information and services, is located on th
Objective. Intrathecal baclofen (ITB) has become the first choice in the management of deleterious s...
This study reports the use of intrathecal baclofen in two ventilator‐dependent children with severe ...
Spasticity may cause immobility, prostration, chronic pain, bedsores, infections, thrombosis and pne...
In the treatment of patients with severe spasticity, intrathecal administration of baclofen (ITB) wa...
Intrathecal baclofen infusion has demonstrated effectiveness in decreasing spasticity of spinal orig...
Flexor and extensor spasms associated with severe spasticity frequently cause pain and suffering in ...
The aim of this thesis was to introduce the intrathecal baclofen delivery method and assessment of i...
Continuous delivery of intrathecal baclofen via an implantable pump was first used to treat severe i...
The purpose of this article is to review the literature on the effects of intrathe-cal[v administere...
Background/Aim. Spasticity is the consequence of several clinical conditions including cerebral pals...
Continuous intrathecal baclofen infusion (CIBI) for spasticity of spinal and cerebral origin has bee...
AimsIntrathecal baclofen (ITB) has proven to be an effective and safe treatment for severe spasticit...
The neuromotor techniques do not have good results in severe spasticity prevention and treatment (As...
Objective. Intrathecal baclofen (ITB) has become the first choice in the management of deleterious s...
The online version of this article, along with updated information and services, is located on th
Objective. Intrathecal baclofen (ITB) has become the first choice in the management of deleterious s...
This study reports the use of intrathecal baclofen in two ventilator‐dependent children with severe ...